Open Access Open Access  Restricted Access Subscription or Fee Access

Review on Azomethine-Compounds with Their Applications

Nagham Mahmood Aljamali, Doaa Alasady, Dr. Huda Sabah Hassen

Abstract


Azomethine derivatives are very important and the initiating compound for most synthetic chemistry
compounds in all their fields. Since R, R1 is an alkyl or aryl group, the first to prepare and isolate it
was the German scientist Hugo Schiff in 1864 from the condensation of the carbonyl group (aldehyde,
ketone) with a primary amine compound (aliphatic, aromatic). During the past few decades there has
been great interest in Schiff base compounds. The rules of the lip stone are the basis for the construction
of modern chemistry. Since the presence of the azomethine group is responsible for the various
biological activities in these compounds, they are used as anti-bacterial and anti-fungal, anti-cancer,
antiviral and plant growth regulators, antidepressant and anti-inflammatory, as well as being used in
the fight against HIV, anti-malarial and antipyretic. In the industrial field, azomethine derivatives were
used when they were associated with azo groups in the manufacture of dyes for fabrics, textiles and
cotton that contain nylon to give colors between yellow and coffee. It is considered one of the stable
and stable dyes at different temperatures.


Full Text:

PDF

References


Nagham Mahmood Aljamali. Synthesis and Investigation of Formazane compounds (Azo– Imine) and their complexes, Asian J. Research Chem.2014; 7 (2): 225-231. 2. Fei, Na; Sauter, Basilius; Gillingham, Dennis. "The pK a of Brønsted acids controls their reactivity with diazo compounds". Chemical Communications.2016; 52(47): 7501–7504. 3. Nagham Mahmood Aljamali, Intisar Obaid Alfatlawi. "Synthesis of Sulfur Heterocyclic Compounds and Study of Expected Biological Activity", Research J. Pharm. and Tech. 2015; 8(9):1225-1242. 4. Nagham Mahmood Aljamali, Imad Kareem Alwan Alsabri., Development of Trimethoprim Drug and Innovation of Sulfazane-Trimethoprim Derivatives as Anticancer Agents., Biomedical & Pharmacology Journal. March 2020;13(2): 613-625. 5. Naumann d'Alnoncourt, Raoul; Csepei, Lénárd-István; Hävecker, Michael; Girgsdies, Frank; Schuster, Manfred E.; Schlögl, Robert; Trunschke, Annette (2014). "The reaction network in propane oxidation over phase-pure MoVTeNb M1 oxide catalysts". Journal of Catalysis.2014; 311: 369–385. 6. Dub, Pavel A.; Gordon, John C. (2018). "The role of the metal-bound N–H functionality in Noyori-type molecular catalysts". Nature Reviews Chemistry.2018; 2 (12): 396–408. 7. Ramasubbu N, Parthasarathy R. Short S…O contacts: structure of 2,5-bis (p-methoxyphenyl hydroxymethyl) thiophene. Acta Crystallogr C.1989; 45:457–460. 8. Pirrung MC, Panasare SV, Sarma KD, et al. Combinatorial optimization of isatin-beta-thiosemi carbazones as anti-poxvirus agents. J Med Chem.2005; 48:3045–50. 9. Potter DE, Russell KR, Manhiani M. Bremazocine increases C-type natriuretic peptide levels in aqueous humor and enhances outflow facility. J Pharmacol Exp Ther.2004; 309:548–53. 10. Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocrine Rev.2006; 27:47–72. 11. Reeve JL, Duffy AM, O’Brien T, et al. Don’t lose heart – therapeutic value of apoptosis prevention in the treatment of cardiovascular disease. J Cell Mol Med. 2005; 9:609–622. 12. Reinoso RF, Telfer BA, Rowland M. Tissue water content in rats measured by desiccation. J Pharmacol Toxicol Methods. 1997; 38:87–92. 13. Rose CD, Martin TM. Caspase recruitment domain 15 mutations and rheumatic diseases. Curr Opin Rheumatol. 2005; 17:579–85. 14. Rowell EA, Wells AD. The role of cyclin-dependent kinases in T-cell development, proliferation, and function. Crit Rev Immunol. 2006; 26:189–212. 15. Sandler M, Przyborowska A, Halket J, et al. Urinary but not brain isatin levels are reduced in germ-free rats. J Neurochem. 1991; 57:1074–1085. 16. Senderowicz AM. Novel small molecule cyclin-dependent kinases modulators in human clinical trials. Cancer Biol Ther. 2003;2: S84–95. 17. Shimizu T, Uehara T, Nomura Y. Possible involvement of pyruvate kinase in acquisition of tolerance to hypoxic stress in glial cells. J Neurochem. 2004; 91:167–75. 18. Shuttleworth SJ, Nasturica D, Gervais CM, et al. Parallel synthesis of isatin-based serine protease inhibitors. Bioorg Med Chem Let. 2000; 10:2501–4. 19. Harish K, Sadique AJ, Suroor AK, Mohammad A. 1,3,4-Oxadiazole/thiadiazole and 1,2,4-triazole derivatives of biphenyl-4-yloxy acetic acid: synthesis and preliminary evaluation of biological properties. Eur J Med Chem.2008; 43:2688–2698.

Liesen AP, et. al. Synthesis and evaluation of anti-Toxoplasma gondii and antimicrobial activities of thiosemicarbazides, 4-thiazolidinones and 1,3,4-thiadiazoles. Eur J Med Chem. 2010; 45:3685–3691. 21. Padmavathi V, et. al. Synthesis, antimicrobial and cytotoxic activities of 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazoles. Eur J Med Chem. 2009; 44:2106–2112. 22. Shiradkar MR, Murahari KK, et. al. Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents. Bioorg Med Chem. 2007; 15:3997–4008. 23. Schenone S, Brullo C, Bruno O, Bondavalli F, Ranise A, Filippelli W, et al. New 1,3,4-thiadiazole derivatives endowed with analgesic and anti-inflammatory activities. Bioorg Med Chem. 2006; 14:1698–1705. 24. Siwek A, Wujec M, Dobosz M, Wawrzycka-Gorczyca I. Study of direction of cyclization of 1-azolil-4-aryl/alkyl-thiosemicarbazides. Heteroat Chem.2010;21(7):521–532. 25. Turan-Zitouni G, Kaplancikli ZA, et. al. Synthesis and analgesic activity of some triazoles and triazolothiadiazines. Farmaco. 1999; 54:218–223. 26. Ulusoy N, Gürsoy A, Ötük G. Synthesis and antimicrobial activity of some 1,2,4-triazole-3-mercaptoacetic acid derivatives. Farmaco. 2001; 56:947–952. 27. Wei Q-L, Zhang S-S. et. al. Synthesis and QSAR studies of novel triazole compounds containing thioamide as potential antifungal agents. Bioorg Med Chem. 2006; 14:7146–7153. 28. White EL, Suling WJ, Ross LJ, Seitz LE, Reynolds RC. 2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ. J Antimicrob Chemother. 2002; 50:111–114. 29. A. J. C. Wilson,V. Geist,. International tables for crystallography. first edition. Dordrecht: Kluwer Academic Publishers; 1995. 30. Wujec M, Paneth P. Mechanism of 4-methyl-1,2,4-triazol-3-thiole reaction with formaldehyde. A DFT study. J Phys Org Chem. 2007; 20:1043–1049. 31. Polovkovych S.V., Karkhut A.I., Marintsova N.G., Lesyk R.B., Zimenkovsky B.S., Novikov V.P. Synthesis of New Schiff Bases and Polycyclic Fused Thiopyranothiazoles Containing 4,6-Dichloro-1,3,5-Triazine Moiety. J. Heterocycl. Chem. 2013; 50:1419–1424. 32. Metwally N.H. A convenient synthesis of some new 5-substituted-4-thioxo-thiazolidines and fused thiopyrano[2,3-d] thiazole derivatives. Phosphorus Sulfur Silicon Relat. Elem. 2008; 183:2073–2085. 33. P. Samadhiya, R. Sharma, et. al. “Synthesis of 2-oxoazetidine derivatives of 2-aminothiazole and their biological activity,” Journal of the Serbian Chemical Society.2012;77(5):599–605.

S. K. Sonwane and S. D. Srivastava, “Synthesis and biological significance of 2-amino-4-phenyl-1,3-thiazole derivatives,” Proceedings of the National Academy of Sciences, India,78(2).129–136, 2008.

H. L. Siddiqui, M. Zia-Ur-Rehman, N. Ahmad, G. W. Weaver, and P. D. Lucas, “Synthesis and antibacterial activity of bis[2-amino-4-phenyl-5-thiazolyl] disulfides,” Chemical and Pharmaceutical Bulletin.2007;55(7),1014–1017.

E. A. Kesicki, M. A. Bailey, Y. Ovechkina et al., “Synthesis and evaluation of the 2-aminothiazoles as anti-tubercular agents,” PLOS ONE.2016;11(5).

P. Lin, R. Hou, et. al, “Efficient Synthesis of 2-Aminothiazoles and Fanetizole in Liquid PEG-400 at Ambient Conditions,” Journal of the Chinese Chemical Society.2009;56(3):455–458, 2009.

M. J. Gorczynski, R. M. Leal, et. al., “Synthesis and evaluation of substituted 4-aryloxy- and 4-arylsulfanyl- phenyl-2-aminothiazoles as inhibitors of human breast cancer cell proliferation,” Bioorganic and Medicinal Chemistry.2004;12(5):1029–1036.

R. N. Misra, H.-Y. Xiao, D. K. Williams et al., “Synthesis and biological activity of N-aryl-2-aminothiazoles: potent pan inhibitors of cyclin-dependent kinases,” Bioorganic and Medicinal Chemistry Letters.2004;14(11):2973–2977.

H. I. El-Subbagh, A. H. Abadi, et. al, “Synthesis and Antitumor Activity of Ethyl 2-Substituted-aminothiazole-4-carboxylate Analogs,” Archiv der Pharmazie.332(4);137–142:1999.

I. Kayagil and S. Demirayak, “Synthesis and anticancer activities of some thiazole derivatives,” Phosphorus, Sulfur and Silicon and the Related Elements.2009;184(9):2197–2207.

Priyanka, K. S. Neeraj, and K. J. Keshari, “Benzothiazole: the molecule of diverse biological activities,” International Journal of Current Pharmaceutical Research.2010;2(1).

H. P. Singh, C. S. Sharma, and C. P. Gautam, “Synthesis and pharmacological screening of some novel 2-arylhydrazino and 2-aryloxy-pyrimido [2,1-b] benzothiazole derivatives,” American-Eurasian Journal of Scientific Research.2009;4(4):222–228.

H. Kaur, S. Kumar, I. Singh, K. K. Saxena, and A. Kumar, “Synthesis, characterization and biological activity of various substituted benzothiazole derivatives,” Digest Journal of Nanomaterials & Biostructures.2010;5(1):67–76.


Refbacks

  • There are currently no refbacks.